AE Wealth Management LLC Has $1.20 Million Position in Stryker Corporation $SYK

AE Wealth Management LLC increased its position in shares of Stryker Corporation (NYSE:SYK) by 31.1% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,037 shares of the medical technology company’s stock after buying an additional 720 shares during the period. AE Wealth Management LLC’s holdings in Stryker were worth $1,202,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Mid American Wealth Advisory Group Inc. acquired a new position in shares of Stryker during the second quarter valued at about $26,000. Sachetta LLC raised its position in Stryker by 58.7% in the second quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after acquiring an additional 27 shares during the period. Ridgewood Investments LLC grew its holdings in Stryker by 48.4% during the second quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock valued at $36,000 after purchasing an additional 30 shares during the period. Ransom Advisory Ltd purchased a new stake in Stryker in the 1st quarter worth about $37,000. Finally, Solstein Capital LLC bought a new stake in shares of Stryker in the second quarter valued at approximately $43,000. 77.09% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have issued reports on SYK shares. Rothschild Redb upgraded shares of Stryker to a “hold” rating in a research note on Thursday, September 18th. Needham & Company LLC boosted their price target on shares of Stryker from $442.00 to $448.00 and gave the stock a “buy” rating in a research note on Friday, August 1st. Truist Financial reiterated a “hold” rating and set a $392.00 price target (down from $407.00) on shares of Stryker in a report on Monday, November 3rd. BTIG Research upped their target price on Stryker from $408.00 to $410.00 and gave the company a “buy” rating in a report on Friday, October 31st. Finally, Wells Fargo & Company increased their price objective on Stryker from $435.00 to $445.00 and gave the stock an “overweight” rating in a report on Friday, August 1st. Thirteen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $433.37.

Insider Buying and Selling at Stryker

In related news, insider Viju Menon sold 500 shares of the business’s stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $390.61, for a total value of $195,305.00. Following the sale, the insider directly owned 12,511 shares in the company, valued at approximately $4,886,921.71. The trade was a 3.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Ronda E. Stryker sold 276,173 shares of the stock in a transaction that occurred on Thursday, November 6th. The shares were sold at an average price of $353.28, for a total value of $97,566,397.44. Following the transaction, the director directly owned 2,702,108 shares of the company’s stock, valued at approximately $954,600,714.24. The trade was a 9.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 520,500 shares of company stock worth $184,803,065. Corporate insiders own 5.20% of the company’s stock.

Stryker Price Performance

NYSE SYK opened at $367.65 on Thursday. The business’s fifty day moving average price is $372.98 and its 200-day moving average price is $381.24. The stock has a market capitalization of $140.60 billion, a price-to-earnings ratio of 48.70, a PEG ratio of 2.66 and a beta of 0.94. Stryker Corporation has a 1-year low of $329.16 and a 1-year high of $406.19. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.06.

Stryker (NYSE:SYK) last released its earnings results on Thursday, October 30th. The medical technology company reported $3.19 earnings per share for the quarter, beating the consensus estimate of $3.13 by $0.06. The company had revenue of $6.06 billion for the quarter, compared to the consensus estimate of $6.04 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.Stryker’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same period in the previous year, the business earned $2.87 earnings per share. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. On average, equities analysts predict that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.